The role of endothelin-1 in the doxorubicin cardiotoxicity
Background: The cardiotoxicity of doxorubicin (Dx), an antineoplastic drug, is imposed by the development of cardiomyopathy and heart failure. The expression of endothelin-1 (ET-1) in myocardium under the action of Dx, directly correlates with the degree of cardiac dysfunction, mediated by endothe...
Main Author: | Lilia Tacu |
---|---|
Format: | Article |
Language: | English |
Published: |
Scientific Medical Association of Moldova
2020-10-01
|
Series: | The Moldovan Medical Journal |
Subjects: | |
Online Access: | http://moldmedjournal.md/wp-content/uploads/2020/09/moldovan-med-j-2020-63-4-tacu-full-text.pdf |
Similar Items
-
Ultrastructural and Echocardiographic Assessment of Chronic Doxorubicin-Induced Cardiotoxicity in Rats
by: H. Babaei, et al.
Published: (2020-03-01) -
Loss of endothelial cell-specific autophagy-related protein 7 exacerbates doxorubicin-induced cardiotoxicity
by: Albert Z. Luu, et al.
Published: (2021-03-01) -
Cardioprotective Effects of Mebudipine in a Rat Model of Doxorubicin-Induced Heart Failure
by: Ehsan Aali, et al.
Published: (2021-03-01) -
The role of iron in anthracycline cardiotoxicity
by: Elena eGammella, et al.
Published: (2014-02-01) -
Efficacy of Dexrazoxane in Preventing Anthracycline Cardiotoxicity in Breast Cancer
by: Ariane V.S. Macedo, MD, MSc, et al.
Published: (2019-09-01)